CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 195 of 1

Non-Antibody Products
Page 195 of 1,333
  • Records 9,701 - 9,750 of 66,623
Name Description Size Catalog #
C53 A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… 5 mg 37354-5 More Info
C53 A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… 50 mg 37354-50 More Info
C646 An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… 1 mg 10549-1 More Info
C646 An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… 10 mg 10549-10 More Info
C646 An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… 5 mg 10549-5 More Info
C-7280948 A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) 1 g 21601-1 More Info
C-7280948 A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) 100 mg 21601-100 More Info
C-7280948 A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) 250 mg 21601-250 More Info
C-7280948 A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) 500 mg 21601-500 More Info
C82 An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… 1 mg 33563-1 More Info
C82 An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… 10 mg 33563-10 More Info
C82 An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… 5 mg 33563-5 More Info
C-87 An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… 10 mg 36578-10 More Info
C-87 An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… 25 mg 36578-25 More Info
C-87 An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… 5 mg 36578-5 More Info
C10-200 An ionizable cationic lipid; has been used in the generation of LNPs for t… 10 mg 40863-10 More Info
C10-200 An ionizable cationic lipid; has been used in the generation of LNPs for t… 25 mg 40863-25 More Info
C10-200 An ionizable cationic lipid; has been used in the generation of LNPs for t… 5 mg 40863-5 More Info
C10-200 An ionizable cationic lipid; has been used in the generation of LNPs for t… 50 mg 40863-50 More Info
C9-200 An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… 1 mg 40862-1 More Info
C9-200 An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… 10 mg 40862-10 More Info
C9-200 An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… 25 mg 40862-25 More Info
C9-200 An ionizable cationic lipid; LNPs containing C9-200 and encapsulating EPO… 5 mg 40862-5 More Info
C3001a An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… 1 mg 31064-1 More Info
C3001a An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… 10 mg 31064-10 More Info
C3001a An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… 5 mg 31064-5 More Info
CA-074 A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… 1 mg 24679-1 More Info
CA-074 A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… 500 µg 24679-500 More Info
CA-4948 An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… 1 mg 27598-1 More Info
CA-4948 An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… 10 mg 27598-10 More Info
CA-4948 An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… 25 mg 27598-25 More Info
CA-4948 An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… 5 mg 27598-5 More Info
CA77.1 An inducer of chaperone-mediated autophagy; induces the formation of autop… 1 mg 37300-1 More Info
CA77.1 An inducer of chaperone-mediated autophagy; induces the formation of autop… 10 mg 37300-10 More Info
CA77.1 An inducer of chaperone-mediated autophagy; induces the formation of autop… 25 mg 37300-25 More Info
CA77.1 An inducer of chaperone-mediated autophagy; induces the formation of autop… 5 mg 37300-5 More Info
C14-A1 An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… 1 mg 40256-1 More Info
C14-A1 An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… 10 mg 40256-10 More Info
C14-A1 An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… 5 mg 40256-5 More Info
Cabazitaxel A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… 10 mg 22262-10 More Info
Cabazitaxel A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… 25 mg 22262-25 More Info
Cabazitaxel A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… 5 mg 22262-5 More Info
Cabazitaxel A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… 50 mg 22262-50 More Info
Cabazitaxel-d9 An internal standard for the quantification of cabazitaxel by GC- or LC-MS 1 mg 28488-1 More Info
Cabazitaxel-d9 An internal standard for the quantification of cabazitaxel by GC- or LC-MS 5 mg 28488-5 More Info
Cabergoline A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… 1 mg 23934-1 More Info
Cabergoline A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… 10 mg 23934-10 More Info
Cabergoline A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… 5 mg 23934-5 More Info
Cabergoline A potent and selective dopamine D2 receptor agonist (Kis = 0.912 and 6,935… 50 mg 23934-50 More Info
Cabergoline-d6 An internal standard for the quantification of cabergoline by GC- or LC-MS 1 mg 31690-1 More Info
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640

Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com

http://www.caymanchem.com

Facebook

Twitter


Return to Profile

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.